• Je něco špatně v tomto záznamu ?

The evaluation of benefit of newly prepared reversible inhibitors of acetylcholinesterase and commonly used pyridostigmine as pharmacological pretreatment of soman-poisoned mice

J. Kassa, J. Korábečný, E. Nepovimová

. 2017 ; 60 (1) : 37-43. [pub] 20170418

Jazyk angličtina Země Česko

Typ dokumentu časopisecké články

Perzistentní odkaz   https://www.medvik.cz/link/bmc17026008

AIM: The ability of four newly prepared reversible inhibitors of acetylcholinesterase (6-chlorotacrine, 7-phenoxytacrine, compounds 1 and 2) and currently used carbamate pyridostigmine to increase the resistance of mice against soman and the efficacy of antidotal treatment of soman-poisoned mice was evaluated. METHODS: The evaluation of the effect of pharmacological pretreatment is based on the identification of changes of soman-induced toxicity that was evaluated by the assessment of its LD50 value and its 95% confidence limit using probitlogarithmical analysis of death occurring within 24 h after administration of soman. RESULTS: 6-chlorotacrine was only able to markedly protect mice against acute toxicity of soman. In addition, the pharmacological pretreatment with 6-chlorotacrine or compound 2 was able to increase the efficacy of antidotal treatment (the oxime HI-6 in combination with atropine) of soman-poisoned mice. The other newly prepared reversible inhibitors of acetylcholinesterase (7-phenoxytacrine, compound 1) as well as commonly used pyridostigmine did not influence the efficacy of antidotal treatment. CONCLUSION: These findings demonstrate that pharmacological pretreatment of somanpoisoned mice can be promising and useful in the case of administration of 6-chlorotacrine and partly compound 2.

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc17026008
003      
CZ-PrNML
005      
20180530143602.0
007      
ta
008      
170824s2017 xr f 000 0|eng||
009      
AR
024    7_
$a 10.14712/18059694.2017.45 $2 doi
035    __
$a (PubMed)28418831
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a xr
100    1_
$a Kassa, Jiří, $u Department of Toxicology and Military Pharmacy, Faculty of Military Health Sciences, University of Defence, Hradec Králové, Czech Republic $d 1956- $7 mzk2003181395
245    14
$a The evaluation of benefit of newly prepared reversible inhibitors of acetylcholinesterase and commonly used pyridostigmine as pharmacological pretreatment of soman-poisoned mice / $c J. Kassa, J. Korábečný, E. Nepovimová
520    9_
$a AIM: The ability of four newly prepared reversible inhibitors of acetylcholinesterase (6-chlorotacrine, 7-phenoxytacrine, compounds 1 and 2) and currently used carbamate pyridostigmine to increase the resistance of mice against soman and the efficacy of antidotal treatment of soman-poisoned mice was evaluated. METHODS: The evaluation of the effect of pharmacological pretreatment is based on the identification of changes of soman-induced toxicity that was evaluated by the assessment of its LD50 value and its 95% confidence limit using probitlogarithmical analysis of death occurring within 24 h after administration of soman. RESULTS: 6-chlorotacrine was only able to markedly protect mice against acute toxicity of soman. In addition, the pharmacological pretreatment with 6-chlorotacrine or compound 2 was able to increase the efficacy of antidotal treatment (the oxime HI-6 in combination with atropine) of soman-poisoned mice. The other newly prepared reversible inhibitors of acetylcholinesterase (7-phenoxytacrine, compound 1) as well as commonly used pyridostigmine did not influence the efficacy of antidotal treatment. CONCLUSION: These findings demonstrate that pharmacological pretreatment of somanpoisoned mice can be promising and useful in the case of administration of 6-chlorotacrine and partly compound 2.
650    _2
$a zvířata $7 D000818
650    _2
$a cholinesterasové inhibitory $x farmakologie $7 D002800
650    _2
$a kombinovaná farmakoterapie $7 D004359
650    _2
$a lidé $7 D006801
650    _2
$a isochinoliny $7 D007546
650    _2
$a mužské pohlaví $7 D008297
650    _2
$a myši $7 D051379
650    _2
$a pyridinové sloučeniny $x aplikace a dávkování $x farmakologie $7 D011726
650    _2
$a pyridostigmin-bromid $x farmakologie $7 D011729
650    _2
$a soman $x otrava $7 D012999
655    _2
$a časopisecké články $7 D016428
700    1_
$a Korábečný, Jan $u Department of Toxicology and Military Pharmacy, Faculty of Military Health Sciences, University of Defence, Hradec Králové, Czech Republic $7 xx0119837
700    1_
$a Nepovímová, Eugenie $u Department of Toxicology and Military Pharmacy, Faculty of Military Health Sciences, University of Defence, Hradec Králové, Czech Republic $7 xx0224758
773    0_
$w MED00010947 $t Acta Medica (Hradec Kralove) $x 1211-4286 $g Roč. 60, č. 1 (2017), s. 37-43
856    41
$u https://actamedica.lfhk.cuni.cz/media/pdf/18059694.2017.45.pdf $y plný text volně přístupný
910    __
$a ABA008 $b A 3077 $c 1072 $y 4 $z 0
990    __
$a 20170824 $b ABA008
991    __
$a 20180530143756 $b ABA008
999    __
$a ok $b bmc $g 1246207 $s 986955
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2017 $b 60 $c 1 $d 37-43 $e 20170418 $i 1211-4286 $m Acta Medica $n Acta Med. (Hradec Král.) $x MED00010947
LZP    __
$b NLK118 $a Pubmed-20170824

Najít záznam

Citační ukazatele

Nahrávání dat ...

    Možnosti archivace